Nasdaq Fertility Firm Newgenivf Sold 146,432 XRP for a $10,849 Profit

Newgenivf's 146,432 XRP Round Trip

Newgenivf Group Limited, a NASDAQ Capital Market-listed operator of in-vitro fertilization clinics with operations in Cambodia and Kyrgyzstan, bought and fully exited a 146,432 XRP position during 2025, per an amended F-1/A registration statement filed with the SEC. Amendment No. 2, submitted on September 10, carries a Digital Assets note stating the firm began deploying idle cash into Solana, Bitcoin, Ethereum and the XRP Ledger's native token as part of its capital-allocation strategy — while stressing that the activity falls outside its core IVF business. Starting from a zero balance, Newgenivf purchased 146,432.14 XRP and sold every token before December 31, booking a realized gain of just $10,849 — roughly seven cents apiece. The buy-and-flip pattern repeated with 8.77 BTC, which netted $12,569, and 8.95 ETH, which added $223; both were also fully liquidated. Solana was the exception. The company ended the year holding 13,000.23 SOL at a cost basis of $2,906,222 against a year-end fair value of $1,630,827 at roughly $125 per token — an unrealized loss of about $1.28 million. With SOL now trading near $101.69, that shortfall has widened to roughly $1.58 million, exceeding the firm's $942,915 in total realized crypto gains and producing a $332,480 net loss under other income and expense. The filing specifies that Newgenivf conducted no mining, no staking or lending, never traded through third-party platforms and never accepted cryptocurrency from patients. The full XRP exit preceded a difficult 2026 in which the token has fallen 27% year-to-date and drifts toward bear-market territory, even as XRP Ledger activity and spot XRP ETF inflows have topped $1.68 billion.

$2.3B RLUSD Fails to Lift Price

The corporate retreat contrasts with an ecosystem that keeps expanding on paper. A weekly cross-altcoin review published September 12 by research firm 10x Research on its official X account shows XRP fell 6.8% over the week — the steepest decline among the major altcoins tracked — even as Ripple's RLUSD stablecoin pushed its market capitalization above $2.3 billion. Strong ecosystem metrics did nothing to blunt selling pressure in Ripple's cross-border settlement asset, and the desk's wider table told the same story across the board: Ethereum slipped about 2% despite BitMine adding 28,086 ETH to lift its treasury to 5.93 million ETH, roughly 4.9% of supply, with more than 5 million ETH staked. Solana lost around 4%, with its Transaction V1 mainnet activation pushed to September 15. The divergence winner was TRON, up 2.7%, aided by Canary Capital's staking-enabled TRXS ETF beginning to trade on Cboe on September 9 — a fund offering both TRX price exposure and staking yield. BNB, down 1.5%, still leads tokenized equities with roughly $1.27 billion in value and a 44.6% market share on its chain. The week's takeaway, echoed across our altcoin coverage: positive project news alone no longer buys price appreciation, and investors are weighing liquidity and risk appetite first. For holders tracking the XRP token, the RLUSD milestone fits a broader push to route $13 trillion in treasury flows through the XRP Ledger, and follows a week in which whales offloaded 90 million tokens — supply-side headwinds fundamentals have yet to offset. Readers tracking the market in real time can follow live spot and futures prices on Gate.

official X accounthttps://x.com/10xResearch/status/2098776143054725414

$1.3980 Resistance in Focus

COINOTAG's proprietary 42-indicator composite S/R scoring engine rates the $1.3587 support at 80/100, driven by the confluence of the Ichimoku Kijun and the 0.500 Fibonacci level, with spot trading at $1.3626 (up 0.89% over 24 hours) after Bollinger bands compressed against this shelf. The $1.3980 resistance scores 73/100 on Fibo 0.382, BB Middle and SMA 20. Perpetual futures funding sits at 0.0026% with $881.6 million in open interest, and a 2.76 long/short ratio means 73.4% of accounts running leverage are long — a crowded side at a 63/100 Greed reading. RSI at 53.35 with a bearish MACD favors a sideways grind; a firm hold of $1.3587 opens a retest of $1.3980, while losing it targets the $1.2588 support (65/100) and would invalidate the range thesis.